Get started

Senorespharmatechnicalchartsetup

Senores Pharma cmp 568.20 by Daily Chart view since listed*Senores Pharma cmp 568.20 by Daily Chart view since listed* - Support Zone at 552 to 567 Price Band - Resistance Zone at 555 to 565 Price Band - Falling Resistance Trendline Breakout well sustained - Volumes are in good sync with the avg traded quantity - Rising Support Trendline respected by upside momentum - Back to Back Rounding Bottoms converging into VCP Pattern too - *Support Zone test retested, followed up by Breakout seems to be continuing*
NSE:SENORES
by PIYUSHCHAVDA
Fostering global wellnessSenores Pharmaceuticals Ltd - CMP 526.5 About Incorporated in 2015, Senores Pharmaceuticals Ltd manufactures and develops affordable and high-quality complex generics certified by global food and drugs authorities Key Points Business Overview: SPL is global research driven pharmaceutical company which develops and manufactures pharmaceutical products for the Regulated Markets of US, Canada and United Kingdom across various therapeutic areas and dosage forms, with a presence in Emerging Markets. Company develops and manufactures specialty, underpenetrated and complex pharmaceutical products. It also manufactures criticalcare injectables and APIs Production Facilities: a) Atlanta Plant: Company manufactures oral solids (tablets and capsules) at its plant in Atlanta, USA, with an installed capacity of Tablets ~132.48 million and Capsules ~38.40 million b) Ahmedabad Plant: Company has 3 units where it manufactures Small Vial Parenterals, Oral Solids & Liquids and Beta Lactum in millions annually. It has a total installed capacity of ~1460 Million c) API: Company manufactures API with an annual installed capacity of ~169 MT Clientele: Prasco LLC, Lannett Company Inc., Jubilant Cadista Pharmaceuticals Inc., Alkem Laboratories, Sun Pharmaceuticals Industries, Dr. Reddy’s Laboratories Inc. and Cipla USA Inc. Overseas Presence: Company has presence in ~43 countries including the Regulated Markets of US, Canada and the United Kingdom Segment Revenue - FY24: Regulated Markets ~68%, Emerging Markets ~21%, Critical Care Injectables ~3%, API ~6%, Other Operational income ~3% IPO: Company has launched its IPO for Fresh issue of shares and Offer for sale and it lists on December 30th 2024 Source: Screener.in This is just to boost my confidence. No Suggestions for buying. I will keep checking and updating my mistake if last post gone wrong... Disclosure: I am not SEBI registered. The information provided here is for educational purposes only. I will not be responsible for any of your profit/loss with these suggestions. Consult your financial Adviser before making any decisions.
NSE:SENORESLong
by Alleyshah
SENORES : Breakout Candidate#SENORES #breakoutsoon #swingtrade #vcppattern #vcpbreakout SENORES : Swing Trade / Momentum trade >> wait for Retracement till black line >> Volumes and Strength Building up >> Beautiful VCP pattern >> Low Risk High Reward Trade Swing Traders can lock profit at 10% and keep Trailing Please Boost, comment and follow us for more Learnings. Note : Markets are still Tricky and can go either ways so don't be over aggressive while choosing & planning your Trades, Calculate your Position sizing as per the Risk Reward you see and most importantly don't go all in Disc : Charts shared are for learning purpose only, not a Trade recommendation. Do your own research and consult your financial advisor before taking any position.
NSE:SENORESLong
by moneyfesttrading